AXIENCE S.A.S. logo — company profile

AXIENCE S.A.S.

Founded 2001 France France 55 employees Private Equity Health Care, Manufacturing +1

General Information

Company Name AXIENCE S.A.S.
Founded Year 2001
Location France France
Employees 55
Industries Health Care, Manufacturing, Pharmaceutical
Funding Stage Private Equity
Business Model B2B, D2C, E Commerce
Revenue Model Product Sales, Service Fee, One Time Purchase
Social

BounceWatch is an independent company data service, not affiliated with AXIENCE S.A.S.. To contact AXIENCE S.A.S., visit axience.fr.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does AXIENCE S.A.S. compare?

A PDF of AXIENCE S.A.S. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting AXIENCE S.A.S. soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About AXIENCE S.A.S.

AXIENCE S.A.S., a company established in 2001, has carved a distinct niche in the veterinary pharmaceutical sector. Originating as a pharmaceutical operator in 2005, the company boasts a diverse product range that includes both proprietary and generic drugs tailored for a variety of animals including companion animals, equines, bovines, and porcines.

Operating out of France, AXIENCE S.A.S. has leveraged its expertise to specialize deeply in veterinary clinic hygiene and disinfection since 2003. By 2009, the company had further expanded its specialization to include anesthesia and analgesia across all animal species.

The company recently secured a Private Equity Round investment from Motion Equity Partners on 21 February 2024. This influx of capital underscores investor confidence in AXIENCE's strategic vision and its potential for sustained growth within the Health Care, Manufacturing, and Pharmaceutical industries.

Business keywords: pharmaceuticals, veterinary medicine, animal health, drug portfolio, hygiene, disinfection, veterinary clinics, anesthesia, analgesia, companion animals, equine, bovine, porcine, veterinary products, specialized pharmaceuticals

Services & Products

Sale of veterinary medicines and hygiene products
Anesthesia and analgesia solutions
Veterinary hygiene and disinfection products
Support for endangered species conservation

Target Customers

Veterinarians Pet owners Farmers with livestock Animal healthcare providers

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Private Equity Round Undisclosed 1
Motion Equity Partners
21 Feb 2024

AXIENCE S.A.S. Alternatives & Competitors

View All Alternatives
AXIENCE S.A.S. vs
BIO ZOO
BIO ZOO Mexico

Está contigo

172 employees
Manufacturing, Pharmaceutical
AXIENCE S.A.S. vs

Vetsfarma since 1979.

73 employees
Manufacturing, Pharmaceutical
AXIENCE S.A.S. vs

Boehringer Ingelheim - researching, developing, manufacturing and marketing of pharmaceuticals

Late Stage
47532 employees
Biotechnology, Health Care

FAQ About AXIENCE S.A.S.

Axience a été créée en 2001 et est devenue Exploitant pharmaceutique vétérinaire en 2005. Portefeuille de médicaments, princeps et génériques, destinés aux animaux de compagnie, équins, bovins et porcins Très forte spécialisation en hygiène et désinfection des cliniques vétérinaires depuis 2003 et e...
AXIENCE S.A.S. was founded in 2001.
AXIENCE S.A.S. is headquartered in France.
AXIENCE S.A.S. operates in Health Care, Manufacturing and Pharmaceutical. Its work centres on pharmaceuticals, veterinary medicine, animal health and drug portfolio. Its customers include Veterinarians, Pet owners and Farmers with livestock.
AXIENCE S.A.S. has a B2B, D2C and E Commerce business model. Its revenue comes from Product Sales, Service Fee and One Time Purchase.
AXIENCE S.A.S. has approximately 55 employees.
AXIENCE S.A.S. has completed 1 funding round. The latest funding stage is Private Equity.
AXIENCE S.A.S. offers: Sale of veterinary medicines and hygiene products, Anesthesia and analgesia solutions, Veterinary hygiene and disinfection products, Support for endangered species conservation.
Top alternatives and competitors to AXIENCE S.A.S. include BIO ZOO, VETSFARMA LIMITED, Boehringer Ingelheim, Parnell Veterinary Pharmaceuticals, Aratana Therapeutics Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
AXIENCE S.A.S. and BIO ZOO are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for AXIENCE S.A.S., https://bouncewatch.com/company/axience-sas, updated 20 March 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes